Home  »  Companies   »  Looking Closely at the Growth Curve for Asensus Su...

Looking Closely at the Growth Curve for Asensus Surgical Inc. (ASXC)

Asensus Surgical Inc. (AMEX:ASXC) went down by -0.45% from its latest closing price compared to the recent 1-year high of $1.51. The company’s stock price has collected -5.02% of loss in the last five trading sessions.

Is It Worth Investing in Asensus Surgical Inc. (AMEX :ASXC) Right Now?

Plus, the 36-month beta value for ASXC is at 1.34.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


ASXC currently public float of 234.37M and currently shorts hold a 3.76% ratio of that float. Today, the average trading volume of ASXC was 858.11K shares.

ASXC’s Market Performance

ASXC stocks went down by -5.02% for the week, with a monthly drop of -9.66% and a quarterly performance of -33.06%, while its annual performance rate touched -70.92%. The volatility ratio for the week stands at 4.45% while the volatility levels for the past 30 days are set at 6.13% for Asensus Surgical Inc. The simple moving average for the period of the last 20 days is -2.12% for ASXC stocks with a simple moving average of -17.39% for the last 200 days.

Analysts’ Opinion of ASXC

Many brokerage firms have already submitted their reports for ASXC stocks, with Cantor Fitzgerald repeating the rating for ASXC by listing it as a “Overweight.” The predicted price for ASXC in the upcoming period, according to Cantor Fitzgerald is $1.50 based on the research report published on September 08th of the current year 2022.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see ASXC reach a price target of $4. The rating they have provided for ASXC stocks is “Buy” according to the report published on May 26th, 2021.

ASXC Trading at -5.17% from the 50-Day Moving Average

After a stumble in the market that brought ASXC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.07% of loss for the given period.

Volatility was left at 6.13%, however, over the last 30 days, the volatility rate increased by 4.45%, as shares sank -9.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.21% lower at present.

During the last 5 trading sessions, ASXC fell by -5.02%, which changed the moving average for the period of 200-days by -47.29% in comparison to the 20-day moving average, which settled at $0.4287. In addition, Asensus Surgical Inc. saw -62.01% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ASXC starting from Starling William N JR, who sale 27,010 shares at the price of $0.40 back on Jun 13. After this action, Starling William N JR now owns 13,846 shares of Asensus Surgical Inc., valued at $10,804 using the latest closing price.

Kwo Elizabeth, the Director of Asensus Surgical Inc., purchase 18,000 shares at $0.53 during a trade that took place back on Mar 15, which means that Kwo Elizabeth is holding 72,201 shares at $9,558 based on the most recent closing price.

Stock Fundamentals for ASXC

Current profitability levels for the company are sitting at:

  • -803.98 for the present operating margin
  • -171.50 for the gross margin

The net margin for Asensus Surgical Inc. stands at -758.77. Equity return is now at value -52.10, with -46.80 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 11.50.